1. Jobe AH. Animal Models, Learning Lessons to Prevent and Treat Neonatal Chronic Lung Disease. Frontiers in medicine. 2015;2:49.
2. Kinsella JP, Greenough A, Abman SH. Bronchopulmonary dysplasia. Lancet (London, England). 2006;367(9520):1421-1431.
3. Stoll BJ, Hansen NI, Bell EF, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010;126(3):443-456.
4. Abman SH, Bancalari E, Jobe A. The Evolution of Bronchopulmonary Dysplasia after 50 Years. American journal of respiratory and critical care medicine. 2017;195(4):421-424.
5. Jensen EA, Schmidt B. Epidemiology of bronchopulmonary dysplasia. Birth defects research Part A, Clinical and molecular teratology. 2014;100(3):145-157.
6. Northway WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. The New England journal of medicine. 1967;276(7):357-368.
7. Higgins RD, Jobe AH, Koso-Thomas M, et al. Bronchopulmonary Dysplasia: Executive Summary of a Workshop. The Journal of pediatrics. 2018;197:300-308.
8. Ambalavanan N, Van Meurs KP, Perritt R, et al. Predictors of death or bronchopulmonary dysplasia in preterm infants with respiratory failure. J Perinatol. 2008;28(6):420-426.
9. Stoll BJ, Hansen NI, Bell EF, et al. Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. Jama. 2015;314(10):1039-1051.
10. Bose C, Van Marter LJ, Laughon M, et al. Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation. Pediatrics. 2009;124(3):e450-e458.
11. Eriksson L, Haglund B, Odlind V, Altman M, Ewald U, Kieler H. Perinatal conditions related to growth restriction and inflammation are associated with an increased risk of bronchopulmonary dysplasia. Acta Paediatr. 2015;104(3):259-263.
12. Morrow LA, Wagner BD, Ingram DA, et al. Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm Infants. American journal of respiratory and critical care medicine. 2017;196(3):364-374.
13. Hirsch K, Taglauer E, Seedorf G, et al. Perinatal Hypoxia-Inducible Factor Stabilization Preserves Lung Alveolar and Vascular Growth in Experimental BPD. American journal of respiratory and critical care medicine. 2020.
14. Wallace B, Peisl A, Seedorf G, et al. Anti-sFlt-1 Therapy Preserves Lung Alveolar and Vascular Growth in Antenatal Models of Bronchopulmonary Dysplasia. American journal of respiratory and critical care medicine. 2018;197(6):776-787.
15. Kallapur SG, Bachurski CJ, Le Cras TD, Joshi SN, Ikegami M, Jobe AH. Vascular changes after intra-amniotic endotoxin in preterm lamb lungs. American journal of physiology Lung cellular and molecular physiology. 2004;287(6):L1178-L1185.
16. Chou H-C, Li Y-T, Chen C-M. Human mesenchymal stem cells attenuate experimental bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia. American journal of translational research. 2016;8(2):342-353.
17. Hou C, Peng D, Gao L, et al. Human umbilical cord-derived mesenchymal stem cells protect from hyperoxic lung injury by ameliorating aberrant elastin remodeling in the lung of O(2)-exposed newborn rat. Biochem Biophys Res Commun. 2018;495(2):1972-1979.
18. You J, Zhou O, Liu J, et al. Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Alleviate Lung Injury in Rat Model of Bronchopulmonary Dysplasia by Affecting Cell Survival and Angiogenesis. Stem Cells Dev. 2020;29(23):1520-1532.
19. Ionescu L, Byrne RN, van Haaften T, et al. Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action. American journal of physiology Lung cellular and molecular physiology. 2012;303(11):L967-L977.
20. Chaubey S, Thueson S, Ponnalagu D, et al. Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6. Stem Cell Res Ther. 2018;9(1):173.
21. Porzionato A, Zaramella P, Dedja A, et al. Intratracheal administration of clinical-grade mesenchymal stem cell-derived extracellular vesicles reduces lung injury in a rat model of bronchopulmonary dysplasia. American journal of physiology Lung cellular and molecular physiology. 2019;316(1):L6-l19.
22. Willis GR, Fernandez-Gonzalez A, Anastas J, et al. Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation. American journal of respiratory and critical care medicine. 2018;197(1):104-116.
23. Mathieu M, Martin-Jaular L, Lavieu G, Théry C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nature cell biology. 2019;21(1):9-17.
24. Chen WX, Zhou J, Zhou SS, et al. Microvesicles derived from human Wharton's jelly mesenchymal stem cells enhance autophagy and ameliorate acute lung injury via delivery of miR-100. Stem Cell Res Ther. 2020;11(1):113.
25. Ferreira ADF, Gomes DA. Stem Cell Extracellular Vesicles in Skin Repair. Bioengineering (Basel, Switzerland). 2018;6(1).
26. Monsel A, Zhu YG, Gennai S, et al. Therapeutic Effects of Human Mesenchymal Stem Cell-derived Microvesicles in Severe Pneumonia in Mice. American journal of respiratory and critical care medicine. 2015;192(3):324-336.
27. Kang T, Jones TM, Naddell C, et al. Adipose-Derived Stem Cells Induce Angiogenesis via Microvesicle Transport of miRNA-31. Stem cells translational medicine. 2016;5(4):440-450.
28. Wallace B, Peisl A, Seedorf G, et al. Anti-sFlt-1 Therapy Preserves Lung Alveolar and Vascular Growth in Antenatal Models of Bronchopulmonary Dysplasia. American journal of respiratory and critical care medicine. 2018;197(6):776-787.
29. Mason RJ. Biology of alveolar type II cells. Respirology (Carlton, Vic). 2006;11 Suppl:S12-15.
30. Ahn SY, Park WS, Kim YE, et al. Vascular endothelial growth factor mediates the therapeutic efficacy of mesenchymal stem cell-derived extracellular vesicles against neonatal hyperoxic lung injury. Experimental & molecular medicine. 2018;50(4):1-12.
31. Velten M, Heyob KM, Rogers LK, Welty SE. Deficits in lung alveolarization and function after systemic maternal inflammation and neonatal hyperoxia exposure. Journal of applied physiology (Bethesda, Md : 1985). 2010;108(5):1347-1356.
32. Durrani-Kolarik S, Pool CA, Gray A, et al. miR-29b supplementation decreases expression of matrix proteins and improves alveolarization in mice exposed to maternal inflammation and neonatal hyperoxia. American journal of physiology Lung cellular and molecular physiology. 2017;313(2):L339-l349.
33. Kowal J, Tkach M, Théry C. Biogenesis and secretion of exosomes. Current opinion in cell biology. 2014;29:116-125.
34. Bobrie A, Colombo M, Raposo G, Théry C. Exosome secretion: molecular mechanisms and roles in immune responses. Traffic (Copenhagen, Denmark). 2011;12(12):1659-1668.
35. Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell. 2005;121(6):823-835.
36. Rawlins EL, Okubo T, Xue Y, et al. The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. Cell stem cell. 2009;4(6):525-534.
37. Tropea KA, Leder E, Aslam M, et al. Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia. American journal of physiology Lung cellular and molecular physiology. 2012;302(9):L829-837.
38. Hu Y, Wei X, Liao Z, et al. Transcriptome Analysis Provides Insights into the Markers of Resting and LPS-Activated Macrophages in Grass Carp (Ctenopharyngodon idella). International journal of molecular sciences. 2018;19(11).
39. Willis GR, Fernandez-Gonzalez A, Reis M, et al. Mesenchymal stromal cell-derived small extracellular vesicles restore lung architecture and improve exercise capacity in a model of neonatal hyperoxia-induced lung injury. Journal of extracellular vesicles. 2020;9(1):1790874.
40. Quan Y, Wang Z, Gong L, et al. Exosome miR-371b-5p promotes proliferation of lung alveolar progenitor type II cells by using PTEN to orchestrate the PI3K/Akt signaling. Stem Cell Res Ther. 2017;8(1):138.
41. Kallapur SG, Moss TJ, Ikegami M, Jasman RL, Newnham JP, Jobe AH. Recruited inflammatory cells mediate endotoxin-induced lung maturation in preterm fetal lambs. American journal of respiratory and critical care medicine. 2005;172(10):1315-1321.
42. Reinhardt J, Landsberg J, Schmid-Burgk JL, et al. MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy. Cancer research. 2017;77(17):4697-4709.
43. Harding A, Cortez-Toledo E, Magner NL, et al. Highly Efficient Differentiation of Endothelial Cells from Pluripotent Stem Cells Requires the MAPK and the PI3K Pathways. Stem Cells. 2017;35(4):909-919.